1. Erthygl › Ymchwil › Adolygwyd gan gymheiriaid

2. Economic evaluation of Tislelizumab Versus Chemotherapy as Second Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China

   Shi, F., He, Z., Su, H., Wang, L. & Han, S., 16 Tach 2022, Yn: Frontiers in Pharmacology. 13

   Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid